1 / 24

Supplementary Table 2.

Supplementary Table 2. a The #CpG indicates the number of CpG in the sequence region. b The plus(+) and minus(-) indicate the presence and absence of CpG island, respectively. c The plus(+) and minus(-) indicate the presence and absence of candidate methylated site, respectively.

jasper
Download Presentation

Supplementary Table 2.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Table 2. aThe #CpG indicates the number of CpG in the sequence region. bThe plus(+) and minus(-) indicate the presence and absence of CpG island, respectively. cThe plus(+) and minus(-) indicate the presence and absence of candidate methylated site, respectively. dThe minimum P-value shows the most significant p-value in the analyzed region. eThe methylation (%) indicates the ratio of methyl CpG sites to all CpG sites.

  2. Supplementary Table 3. Features of candidate methylated sites are shown. aThe Obs/exp indicates the ratio of observed and expected CpG frequency. bFold-enrichment was calculated based on population of ENCODE probes extracted randomly.

  3. Supplementary Table 4: aThe Upstream CMS shows a location of upstream CMS, if any, by a distance from a TSS. bThe 5Aza+ indicates GeneChip score with 5Aza-dC treatment. cThe 5Aza- indicates GeneChip socre without 5Aza-dC treatment.

  4. Supplementary Figure 1: 400 200 100 50 (ng) 5Aza-dC － ＋ Genomic DNA and demethylated DNA were spotted on a nitrocellulose membrane at 50-400ng. 1st antibody: anti-methycytosine antibody, 2nd antibody: HRP anti-rabbit IgG antibody

  5. -5 -4 -3 -2 -1 0 0 -1 -2 -3 -4 -5 Supplementary Figure 2: A B Log 10(P) 32 16 8 4 MeDIPs vs. Controls ( n = 2 ) MeDIPs vs. Controls ( n = 2 ) MeDIP1 vs. Control1 ( n = 1 ) 2 MeDIP1 vs.. Control1 ( n = 1 ) Control1 vs. Control2 ( n = 1 ) 1 1 2 3 4 5 0 - Log10(P) The scanned tiling array data were analyzed with Tiling Array Analysis Software (Affymetrix). The p-values analyzed in those combinations of 2 MeDIPs vs. 2 Controls, MeDIP1 vs. Control1, Control1 vs. Control2 were obtained. a Number of probes less than each threshold p-value was plotted for each result. b The rates of probe numbers due to threshold p-values were plotted.

  6. Supplementary Figure 3: A

  7. B

  8. C

  9. High-resolution mapping of DNA methylation in the ENCODE region. Tracks for CMS (light green bar), -10×log10(p-value) (vertical yellow bar) and CGI (green bar) are shown. a DLD1, b HCT116, b SW480

  10. Supplementary Figure 4: A B C Bisulfite sequencing of CMS or non-CMS in HCT116. a Genomic view showing CMS on INHA (top). Tracks for sequenced region (pink bar), CMS (light green bar), -10×log10 (P-value) (vertical yellow bar) and CGI (green bar) are shown. Black horizontal bar indicates P=10-2. Result of bisulfite sequencing (bottom). Closed circle and open circle indicate methylated CpG and unmethylated CpG, respectively. bTFEB, cCRAT

  11. Supplementary Figure 5: Results of bisulfite sequencing are shown described in Supplemental Table 3. Number 16 and 19 are shown in Supplemental Fig. 7, and number 17-18 and 26 are shown in Supplemental Fig 4. Number 28-40 are shown in Fig. 4. Closed circle and open circle indicate methylated CpG and unmethylated CpG, respectively.

  12. Supplementary Figure 6: A DLD1_CMS DLD1_CMS DLD1_CMS DLD1_CMS

  13. Supplementary Figure 6: B SW480_CMS SW480_CMS High-resolution mapping of DNA methylation on the HOXA cluster. Tracks for CMS (light green bar), -10×log10(p-value) (vertical yellow bar) and CGI (green bar) are shown. a DLD1, b SW480

  14. Supplementary Figure 7: A B C Comparison of methylation patterns among three colorectal cancer cell lines. a The Venn diagram of CMS in three cell lines. If CMS overlapped at least by one base, we regard them as overlapped CMS. b and c High-resolution mapping of DNA methylation for EXT1 and CFTR, respectively. Tracks for sequenced region (blue bar). CMS and -10×log10(p-value) are shown in yellow bar for DLD1, green for HCT116, and purple for SW480. Results of sequencing are shown at the bottom.

  15. Supplementary Figure 8: MSP analysis of genes overexpressed after 5Aza-dC treatment. a and b High-resolution mapping of DNA methylation for TKTL1 and EXT1, respectively.

  16. Supplementary Figure 9: SERPINB2: serpin peptidase inhibitor, clade B, member 2 TKTL1: transketolase-like 1 HCT116_CMS HCT116_CMS -10×log(P-value) -10×log(P-value) CTAG2: cancer/testis antigen 2 CTAG1B: cancer/testis antigen 1B HCT116_CMS HCT116_CMS -10×log(P-value) -10×log(P-value) PDLIM4: PDZ and LIM domain 4 CTGF: connective tissue growth factor HCT116_CMS HCT116_CMS -10×log(P-value) -10×log(P-value) EXT1: exostoses1 CDH2: N-cadherin HCT116_CMS HCT116_CMS -10×log(P-value) -10×log(P-value) AXIN1: axin 1 RFPL2: ret finger protein-like 2 HCT116_CMS HCT116_CMS -10×log(P-value) -10×log(P-value) DNA methylation maps of genes 10 top-ranking genes overexpressed after 5Aza-dC treatment are shown. Tracks for CMS (light green bar), -10×log10(p-value) (vertical yellow bar) and CGI (green bar), Repeat Masker (black bar) are shown.

More Related